Mayer, S. A., Frontera, J. A., Jankowitz, B., Kellner, C. P., Kuppermann, N., Naik, B. I., . . . Goldstein, J. N. (2021). Recommended primary outcomes for clinical trials evaluating hemostatic agents in patients with intracranial hemorrhage: A consensus statement. JAMA network open, 4(9), . https://doi.org/10.1001/jamanetworkopen.2021.23629
Chicago Style (17th ed.) CitationMayer, Stephan A., Jennifer A. Frontera, Brian Jankowitz, Christopher P. Kellner, Nathan Kuppermann, Bhiken I. Naik, Daniel K. Nishijima, Thorsten Steiner, and Joshua N. Goldstein. "Recommended Primary Outcomes for Clinical Trials Evaluating Hemostatic Agents in Patients with Intracranial Hemorrhage: A Consensus Statement." JAMA Network Open 4, no. 9 (2021). https://doi.org/10.1001/jamanetworkopen.2021.23629.
MLA (9th ed.) CitationMayer, Stephan A., et al. "Recommended Primary Outcomes for Clinical Trials Evaluating Hemostatic Agents in Patients with Intracranial Hemorrhage: A Consensus Statement." JAMA Network Open, vol. 4, no. 9, 2021, https://doi.org/10.1001/jamanetworkopen.2021.23629.